Abnormal cobalamin-dependent transmethylation in AIDS-associated myelopathy

被引:31
作者
Di Rocco, A
Bottiglieri, T
Werner, P
Geraci, A
Simpson, D
Godbold, J
Morgello, S
机构
[1] Beth Israel Deaconess Med Ctr, Albert Einstein Coll Med, Dept Neurol, PACC, New York, NY 10003 USA
[2] Baylor Univ, Med Ctr, Inst Metab Dis, Dallas, TX USA
[3] Mt Sinai Sch Med, Dept Community Med & Stat, New York, NY USA
[4] Mt Sinai Sch Med, Dept Neurol, New York, NY USA
[5] Mt Sinai Sch Med, Dept Pathol, New York, NY USA
关键词
D O I
10.1212/WNL.58.5.730
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: White matter vacuolization of the, spinal cord is common in patients with AIDS and may lead to clinical manifestations of myelopathy. The pathogenesis of AIDS-associated myelopathy (AM) is unknown and may be related to metabolic abnormalities rather than to direct HIV infection. The striking pathologic similarity between AM and the vacuolar myelopathy associated with vitamin B-12 deficiency suggests that abnormal metabolism of the B-12-dependent transmethylation pathway may be important in the pathogenesis of AM. Methods: The authors compared S-adenosylmethionine (SAM), methionine, homocysteine, and glutathione in serum and CSF of 15 patients with AM vs 13 HIV-infected controls without myelopathy (HWM). They also compared the results with a non-HIV-infected reference population (NC). All patients had normal B-12, folate, and methylmalonic acid levels. Results: There was a decrease in CSF SAM in the AM group compared with the HWM group (p<0.0001) and the NC group (p<0.0001). CSF SAM in the HWM group was also lower than that in the NC group (p=0.015). Serum methionine was also reduced in serum of the myelopathic group compared with the NC group (p=0.006). Conclusions: AM is associated with an abnormality of the vitamin B-12-dependent transmethylation pathway.
引用
收藏
页码:730 / 735
页数:6
相关论文
共 30 条
  • [1] TRIMETREXATE FOR THE TREATMENT OF PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME
    ALLEGRA, CJ
    CHABNER, BA
    TUAZON, CU
    OGATAARAKAKI, D
    BAIRD, B
    DRAKE, JC
    SIMMONS, JT
    LACK, EE
    SHELHAMER, JH
    BALIS, F
    WALKER, R
    KOVACS, JA
    LANE, HC
    MASUR, H
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (16) : 978 - 985
  • [2] Biochemical analysis of myelin lipids and proteins in a model of methyl donor pathway deficit:: Effect of S-adenosylmethionine
    Bianchi, R
    Calzi, F
    Savaresi, S
    Sciarretta-Birolo, R
    Bellasio, R
    Tsankova, V
    Tacconi, MT
    [J]. EXPERIMENTAL NEUROLOGY, 1999, 159 (01) : 258 - 266
  • [3] Bottiglieri T, 1996, NUTR REV, V54, P382, DOI 10.1111/j.1753-4887.1996.tb03851.x
  • [4] Boven LA, 1999, J IMMUNOL, V162, P4319
  • [5] CEREBROSPINAL-FLUID S-ADENOSYLMETHIONINE (SAME) AND GLUTATHIONE CONCENTRATIONS IN HIV-INFECTION - EFFECT OF PARENTERAL TREATMENT WITH SAME
    CASTAGNA, A
    LEGRAZIE, C
    ACCORDINI, A
    GIULIDORI, P
    CAVALLI, G
    BOTTIGLIERI, T
    LAZZARIN, A
    [J]. NEUROLOGY, 1995, 45 (09) : 1678 - 1683
  • [6] DALPAN GJ, 1994, NEUROLOGY, V44, P2159
  • [7] A pilot study of l-methionine for the treatment of AIDS-associated myelopathy
    Di Rocco, A
    Tagliati, M
    Danisi, F
    Dorfman, D
    Moise, J
    Simpson, DM
    [J]. NEUROLOGY, 1998, 51 (01) : 266 - 268
  • [8] ABNORMAL AMINO-ACID-CONCENTRATIONS IN THE BLOOD OF PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) MAY CONTRIBUTE TO THE IMMUNOLOGICAL DEFECT
    DROGE, W
    ECK, HP
    NAHER, H
    PEKAR, U
    DANIEL, V
    [J]. BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1988, 369 (03): : 143 - 148
  • [9] The metabolism of homocysteine: pathways and regulation
    Finkelstein, JD
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 1998, 157 (Suppl 2) : S40 - S44
  • [10] ENZYMATIC METHYLATION OF MYELIN BASIC-PROTEIN IN MYELIN
    GHOSH, SK
    RAWAL, N
    SYED, SK
    PAIK, WK
    KIM, S
    [J]. BIOCHEMICAL JOURNAL, 1991, 275 : 381 - 387